These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22752791)

  • 1. Backbone ¹H, ¹³C, and ¹⁵N chemical shift assignment for HIV-1 protease subtypes and multi-drug resistant variant MDR 769.
    Huang X; de Vera IM; Veloro AM; Rocca JR; Simmerling C; Dunn BM; Fanucci GE
    Biomol NMR Assign; 2013 Oct; 7(2):199-202. PubMed ID: 22752791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.
    Bandaranayake RM; Kolli M; King NM; Nalivaika EA; Heroux A; Kakizawa J; Sugiura W; Schiffer CA
    J Virol; 2010 Oct; 84(19):9995-10003. PubMed ID: 20660190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ninety-nine is not enough: molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region.
    Kozísek M; Sasková KG; Rezácová P; Brynda J; van Maarseveen NM; De Jong D; Boucher CA; Kagan RM; Nijhuis M; Konvalinka J
    J Virol; 2008 Jun; 82(12):5869-78. PubMed ID: 18400858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ¹H, ¹³C and ¹⁵N chemical shift assignments for an intracellular proteinase inhibitor of Bacillus subtilis.
    Li Q; Chen AS; Gayen S; Kang C
    Biomol NMR Assign; 2013 Oct; 7(2):129-32. PubMed ID: 22585087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of amino acid variations in Gag and protease of HIV type 1 CRF01_AE strains on drug susceptibility of virus to protease inhibitors.
    Jinnopat P; Isarangkura-na-ayuthaya P; Utachee P; Kitagawa Y; de Silva UC; Siripanyaphinyo U; Kameoka Y; Tokunaga K; Sawanpanyalert P; Ikuta K; Auwanit W; Kameoka M
    J Acquir Immune Defic Syndr; 2009 Nov; 52(3):320-8. PubMed ID: 19727001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs.
    Perryman AL; Lin JH; McCammon JA
    Protein Sci; 2004 Apr; 13(4):1108-23. PubMed ID: 15044738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 protease substrate-groove: Role in substrate recognition and inhibitor resistance.
    Laco GS
    Biochimie; 2015 Nov; 118():90-103. PubMed ID: 26300060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
    Lefebvre E; Schiffer CA
    AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Resistance Mechanism of L10F, L10F/N88S and L90M mutations in CRF01_AE HIV-1 protease: Molecular dynamics simulations and binding free energy calculations.
    Vasavi CS; Tamizhselvi R; Munusami P
    J Mol Graph Model; 2017 Aug; 75():390-402. PubMed ID: 28645089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding kinetics and substrate selectivity in HIV-1 protease-Gag interactions probed at atomic resolution by chemical exchange NMR.
    Deshmukh L; Tugarinov V; Louis JM; Clore GM
    Proc Natl Acad Sci U S A; 2017 Nov; 114(46):E9855-E9862. PubMed ID: 29087351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ¹H, ¹⁵N and ¹³C Backbone resonance assignments of a conformational mutant of the adhesion protein ∆-Bd37 from Babesia divergens.
    Barthe P; Murciano B; Schetters T; Gorenflot A; Delbecq S; Roumestand C
    Biomol NMR Assign; 2013 Oct; 7(2):241-4. PubMed ID: 22899250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes.
    Velazquez-Campoy A; Vega S; Freire E
    Biochemistry; 2002 Jul; 41(27):8613-9. PubMed ID: 12093278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nine crystal structures determine the substrate envelope of the MDR HIV-1 protease.
    Liu Z; Wang Y; Brunzelle J; Kovari IA; Kovari LC
    Protein J; 2011 Mar; 30(3):173-83. PubMed ID: 21394574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the mechanism of drug resistance: X-ray structure analysis of multi-drug resistant HIV-1 protease ritonavir complex.
    Liu Z; Yedidi RS; Wang Y; Dewdney TG; Reiter SJ; Brunzelle JS; Kovari IA; Kovari LC
    Biochem Biophys Res Commun; 2013 Feb; 431(2):232-8. PubMed ID: 23313846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope.
    Ozen A; Haliloğlu T; Schiffer CA
    J Mol Biol; 2011 Jul; 410(4):726-44. PubMed ID: 21762811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR structural and dynamic characterization of the acid-unfolded state of apomyoglobin provides insights into the early events in protein folding.
    Yao J; Chung J; Eliezer D; Wright PE; Dyson HJ
    Biochemistry; 2001 Mar; 40(12):3561-71. PubMed ID: 11297422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity.
    Logsdon BC; Vickrey JF; Martin P; Proteasa G; Koepke JI; Terlecky SR; Wawrzak Z; Winters MA; Merigan TC; Kovari LC
    J Virol; 2004 Mar; 78(6):3123-32. PubMed ID: 14990731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into the South African HIV-1 subtype C protease: impact of hinge region dynamics and flap flexibility in drug resistance.
    Naicker P; Achilonu I; Fanucchi S; Fernandes M; Ibrahim MA; Dirr HW; Soliman ME; Sayed Y
    J Biomol Struct Dyn; 2013 Dec; 31(12):1370-80. PubMed ID: 23140382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights.
    Chetty S; Bhakat S; Martin AJ; Soliman ME
    J Biomol Struct Dyn; 2016; 34(1):135-51. PubMed ID: 25671669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the HIV-1 protease nelfinavir resistance mutation D30N in subtypes B and C through molecular dynamics simulations.
    Soares RO; Batista PR; Costa MG; Dardenne LE; Pascutti PG; Soares MA
    J Mol Graph Model; 2010 Sep; 29(2):137-47. PubMed ID: 20541446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.